Biotechnology Fate Therapeutics (FATE) Loses -50.54% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner January 3, 2023
Biotechnology Halozyme to Present at the 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Biotechnology Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development January 3, 2023
Biotechnology Ascendis Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Biotechnology Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Biotechnology Apellis Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Search
Biotechnology
